In this study, treatment with rapamycin does not affect myofibrillar synthesis, while it decreases the phosphorylation of p70S6K1 and S6, implying that mTOR is not involved in myostatin-mediated myofibrillar synthesis (Welle et al., 2009). The injection of a myostatin antibody enhances phosphorylation of p70S6K1 and S6 in muscle, but does not change phosphorylation of Akt and 4EBP1 in the concomitant increase of myofibrillar synthesis (Welle et al., 2009). Myostatin, a transforming growth factor-β (TGF-β) family member, plays a critical role in inhibiting the growth of muscle mass and muscle cell differentiation (McPherron et al., 1997). In line with mTOR function as a positive regulator of muscle hypertrophy, mTOR signaling is negatively regulated by muscle atrophy-inducing signals or blocks muscle atrophy signals. The loss of skeletal muscle, muscle atrophy, stems from an increase in the rate of protein degradation or the decrease of protein synthesis under various conditions, such as disuse, diseases, and aging. Muscle-specific expression of IGF-I in transgenic mice results in at least a 2-fold increase in muscle hypertrophy (Coleman et al., 1995; Musaro et al., 2001), suggesting that the IGF-I/Akt/mTORC1 pathway is indispensable to muscle hypertrophy. Instead, Akt /mTOR signaling by IGF-I/IGFR/IRS-1 has been shown to be indispensable in prompting muscle hypertrophy (Glass, 2003).
Effect of bicalutamide treatment on mTOR activity. However, this effect only occurred with low testosterone. "This is currently very difficult to study directly because examining newborn nervous system activity in living patients is not feasible. Our goal is to translate these findings into patient care," Dr. Hirunagi said. Female mice with the same mutation showed no such effects, confirming that testosterone is the key trigger." A brief natural spike in testosterone known as the neonatal testosterone surge or "mini-puberty" occurs in all newborn males and lasts approximately 10 days in mice and around 6 months in humans.
Total RNA was extracted from left ventricular myocardial tissue using Trizol reagent. M-mode echocardiography recordings were obtained for the level of papillary muscle. The sign of successful model establishment was that continuous vaginal shedding cell smear examination showed the disappearance of estrous cycle changes in rats and the cell type was estrous interphase I and II. Therefore, mTOR is a crucial regulator of the maintenance of cardiac function under myocardial compensatory and pressure overload. Mammalian rapamycin receptor (mTOR) is a potentially important regulatory factor in various regulatory pathways that affect cardiac function (Huang et al. 2020, Liu & Sabatini 2020). Except for estrogen, changes in androgen levels may contribute to the occurrence of postmenopausal cardiovascular disease.
Myostatin production is also induced by food deprivation in a glucocorticoid-dependent manner (Allen et al., 2010). Human myostatin promoter is reported to have a putative GRE and is responsive to dexamethasone and RU-486, an antagonist of GR (Ma et al., 2001). KlF15 plays a critical role in muscle catabolism through the transcriptional upregulation of atrogen-1, MuRF-1, and branched-chain aminotransferase 2 (BCAT2). Exogenous administration of glucocorticoids induces muscle atrophy and the blockage of GR; adrenalectomy or treatment with the GR antagonist RU486 diminishes muscle atrophy in sepsis, cachexia, starvation, and severe insulinopenia (Menconi et al., 2007; Schakman et al., 2008).
Since mTOR is sensitive to nutrient levels, its activity would be diminished as a result of nutrient deprivation. Chen et al. (18) demonstrated that increased AR protein may amplify the output from residual ligand and alter the response to antagonist. Wang et al. (7) found that rapamycin inhibition of mTORC1 increases AR transcriptional activity via an Akt-dependent pathway downstream of mTORC2. The role of testosterone in glucose deprivation-induced apoptosis was therefore studied. Another experiment with the same protocol was carried out, with the exception that the trypan blue method was used to asses the percentage of dead cells (Figure 6B). To test this hypothesis, an adjuvant bicalutamide protocol was designed in which cells were subjected first to glucose deprivation for three days, followed by bicalutamide treatment for another day.
In addition, myostatin blocks differentiation-inducing genes, such as myogenin and myoD (Trendelenburg et al., 2009), suggesting that myostatin regulates muscle differentiation by modulating both the programs of differentiation and atrophy. The binding of myostatin to the type II activin receptor IIb leads to interaction with the type I receptor ALK4 or ALK5, which results in the phosphorylation and activation of the transcription factors Smad2 and Smad3(Sartori et al., 2014). Myostatin regulates the number of muscle fibers during development and the growth of muscle fibers postnatally (Lee, 2007). In this section, it will be discussed the crosstalk between mTOR and two major muscle atrophy-inducing signals such as myostatin and glucocorticoids.
More importantly, our results suggested that rapamycin alleviated the dysregulation of MMP-9/TIMP-1 balance while improving Testosterone-induced OVX SHR cardiac hypertrophy. In the present study, the high expression of MMP-9 and the low expression of TIMP-1 displayed imbalance in the Testosterone-induced cardiac hypertrophy of OVX SHR. The specific knockout of rheb1 gene in mice under pressure overload can inhibit the expression of mTORC1 and reduce the occurrence of myocardial hypertrophy and myocardial fibrosis (Wu et al. 2013). Testosterone-induced ovariectomy SHR cardiac hypertrophy may be related to the expression of mTORC1/S6K1/4EBP1/eIF4E.

Gender: Female

Social links